A Trial of Lenvatinib Plus Pembrolizumab in Participants With Hepatocellular Carcinoma
Clinical trial NCT03006926 · COMPLETED
Trial details
- NCT number
- NCT03006926
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-13
- Primary completion
- 2019-10-31
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.